Simultaneous Kinase Inhibition with Ibrutinib and BCL2 Inhibition with Venetoclax As a Therapeutic Strategy for Acute Lymphoblastic Leukemia

被引：0
|
作者：
Eide, Christopher A. [1 ,2 ]
Kurtz, Stephen E. [1 ]
Kaempf, Andy [3 ]
Long, Nicola [1 ]
Leonard, Jessica [1 ]
Chang, Bill H. [4 ]
Mori, Motomi [3 ,5 ]
Druker, Brian J. [1 ,2 ]
Tyner, Jeffrey W. [1 ,6 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR 97201 USA
[2] Howard Hughes Med Inst, Portland, OR USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Biostat Shared Resource, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Pediat Hematol & Oncol, Portland, OR 97201 USA
[5] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland State Univ, Portland, OR 97201 USA
[6] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-131288
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3950
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Ibrutinib therapy increases BCL2 dependence and enhances sensitivity to venetoclax in CLL patients
    Deng, Jing
    Isik, Elif
    Fernandes, Stacey
    Brown, Jennifer R.
    Letai, Anthony
    Davids, Matthew
    LEUKEMIA & LYMPHOMA, 2015, 56 : 96 - 97
  • [42] Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models
    Han, Lina
    Zhang, Qi
    Dail, Monique
    Shi, Ce
    Cavazos, Antonio
    Ruvolo, Vivian R.
    Zhao, Yang
    Kim, Eugene
    Rahmani, Mohamed
    Mak, Duncan H.
    Jin, Sha S.
    Chen, Jun
    Phillips, Darren C.
    Koller, Paul Bottecelli
    Jacamo, Rodrigo
    Burks, Jared K.
    DiNardo, Courtney
    Daver, Naval
    Jabbour, Elias
    Wang, Jing
    Kantarjian, Hagop M.
    Andreeff, Michael
    Grant, Steven
    Leverson, Joel D.
    Sampath, Deepak
    Konopleva, Marina
    HAEMATOLOGICA, 2020, 105 (03) : 697 - 707
  • [43] Simultaneous Inhibition of Protein Kinase CK2 and Dihydrofolate Reductase Results in Synergistic Effect on Acute Lymphoblastic Leukemia Cells
    Winska, Patrycja
    Widlo, Lukasz
    Skierka, Katarzyna
    Krzysko, Alicja
    Koronkiewicz, Miroslawa
    Ciesla, Jaroslaw M.
    Ciesla, Joanna
    Bretner, Maria
    ANTICANCER RESEARCH, 2019, 39 (07) : 3531 - 3542
  • [44] MERTK inhibition in the leukemia microenvironment promotes a therapeutic immune response to acute lymphoblastic leukemia
    Jacobsen, Kristen M.
    Lee-Sherick, Alisa B.
    Huey, Madeline G.
    Page, Lauren S.
    Zhang, Weihe
    Wang, Xiaodong
    Fyre, Stephen V.
    Earp, H. Shelton
    Jordan, Craig T.
    DeRyckere, Deborah
    Graham, Douglas K.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [45] Induction of apoptosis in pediatric acute lymphoblastic leukemia (ALL) cells by the therapeutic opioid methadone and effective synergy with Bcl-2 inhibition
    Singh, Anjali
    Jayanthan, Aarthi
    Farran, Allyson
    Elwi, Adam N.
    Kim, Sung-Woo
    Farran, Peter
    Narendran, Aru
    LEUKEMIA RESEARCH, 2011, 35 (12) : 1649 - 1657
  • [46] TARGETING BET FAMILY PROTEINS IMPROVES THE THERAPEUTIC EFFICACY OF BCL-2 INHIBITION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Peirs, S.
    Frismantas, V.
    Matthijssens, F.
    Lintermans, B.
    Pieters, T.
    Vandamme, N.
    Van Loocke, W.
    Berx, G.
    Poppe, B.
    Bourquin, J. P.
    Van Vlierberghe, P.
    HAEMATOLOGICA, 2016, 101 : 201 - 202
  • [47] Inhibition of Unc-51 like Autophagy Activating Kinase 1 (ULK1) Is Highly Synergistic with Chemotherapy and Bcl2 Inhibition in Acute Myeloid Leukemia (AML)
    Bhattacharya, Seemana
    Piya, Sujan
    McQueen, Teresa
    Konopleva, Marina
    Andreeff, Michael
    Borthakur, Gautam
    BLOOD, 2017, 130
  • [48] PKC α mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation
    Jiffar, T
    Kurinna, S
    Suck, G
    Carlson-Bremer, D
    Ricciardi, MR
    Konopleva, M
    Andreeff, M
    Ruvolo, PP
    LEUKEMIA, 2004, 18 (03) : 505 - 512
  • [49] Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia
    Tausch, Eugen
    Close, William
    Dolnik, Anna
    Bloehdorn, Johannes
    Chyla, Brenda
    Bullinger, Lars
    Doehner, Hartmut
    Mertens, Daniel
    Stilgenbauer, Stephan
    HAEMATOLOGICA, 2019, 104 (09)
  • [50] PKC α mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation
    T Jiffar
    S Kurinna
    G Suck
    D Carlson-Bremer
    M R Ricciardi
    M Konopleva
    M Andreeff
    P P Ruvolo
    Leukemia, 2004, 18 : 505 - 512
12345